(2S)-1-[4-[[1-(1,3-benzodioxol-5-yl)imidazol-4-yl]amino]thieno[2,3-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide
C21H19N7O3S — CID 142498688
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-1-[4-[[1-(1,3-benzodioxol-5-yl)imidazol-4-yl]amino]thieno[2,3-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide
(2S)-1-[4-[[1-(1,3-benzodioxol-5-yl)imidazol-4-yl]amino]thieno[2,3-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide (PubChem CID 142498688) has the molecular formula C21H19N7O3S and a molecular weight of 449.50 g/mol. Its IUPAC name is (2S)-1-[4-[[1-(1,3-benzodioxol-5-yl)imidazol-4-yl]amino]thieno[2,3-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S)-1-[4-[[1-(1,3-benzodioxol-5-yl)imidazol-4-yl]amino]thieno[2,3-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 142498688 |
| Molecular Formula | C21H19N7O3S |
| Molecular Weight | 449.50 g/mol |
| Exact Mass | 449.13 |
| IUPAC Name | (2S)-1-[4-[[1-(1,3-benzodioxol-5-yl)imidazol-4-yl]amino]thieno[2,3-d]pyrimidin-2-yl]pyrrolidine-2-carboxamide |
| SMILES | NC(=O)[C@@H]1CCCN1c1nc(Nc2cn(-c3ccc4c(c3)OCO4)cn2)c2ccsc2n1 |
| InChI | InChI=1S/C21H19N7O3S/c22-18(29)14-2-1-6-28(14)21-25-19(13-5-7-32-20(13)26-21)24-17-9-27(10-23-17)12-3-4-15-16(8-12)31-11-30-15/h3-5,7-10,14H,1-2,6,11H2,(H2,22,29)(H,24,25,26)/t14-/m0/s1 |
| InChIKey | LAKDJSKNERSLMT-AWEZNQCLSA-N |
| XLogP | 2.80 |
| TPSA | 120.42 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.50 |
| LogP ≤ 5 | 2.80 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142498688 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.